Revenue: The sum of all revenue fields included for a company's operating activities.
Aprea Therapeutics, Inc. (APRE) had Revenue of $0.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$0.00M |
$-2.46M |
|
-- |
|
$0.00M |
|
$2.65M |
|
$-2.64M |
|
$0.19M |
|
$-2.46M |
|
$-2.46M |
|
$-2.46M |
|
$-2.46M |
|
$-2.46M |
|
$-2.46M |
|
$-2.64M |
|
$-2.64M |
|
6.54M |
|
6.54M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$15.56M |
|
$0.06M |
|
$0.37M |
|
$15.93M |
|
$2.76M |
|
-- |
|
$0.73M |
|
$3.49M |
|
$12.44M |
|
$12.44M |
|
$12.44M |
|
8.19M |
|
| Cash Flow Statement Financials | |
$-12.89M |
|
-- |
|
$4.64M |
|
$22.89M |
|
$14.64M |
|
$-8.25M |
|
$0.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-79205.77% |
|
-79205.78% |
|
-- |
|
-73588.05% |
|
-73588.06% |
|
$-12.89M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-19.74% |
|
-19.74% |
|
-15.41% |
|
-19.74% |
|
$1.52 |
|
$-1.97 |
|
$-1.97 |
|